Our study screened out a series of TFs and miRNAs as promising candidates for the upstream targets of SDPR in KRAS-mutant cancers, and we constructed a ceRNA regulation network of SDPR in KRAS mutant lung cancers, which provided useful information for the molecule regulatory network of SDPR in KRAS-mutant lung cancers. This evidence concerns the gene KRAS and lung carcinoma.